Journal article
ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
- Abstract:
- Obstructive sleep apnoea (OSA), atrial fibrillation (AF) and sudden cardiac death (SCD) may occur concomitantly, and are of considerable epidemiological interest, potentially leading to morbidity and mortality. Effective treatment of OSA with continuous positive airway pressure (CPAP) could prevent progression and/or recurrence of AF and factors leading to SCD. Recently, a randomised controlled trial showed a statistically and clinically significant prolongation of measures of cardiac repolarisation after CPAP withdrawal in symptomatic patients with moderate to severe OSA. Whether or not CPAP therapy improves ECG risk markers of AF and SCD in patients with minimally symptomatic OSA as well, is unknown.3 centres taking part in the MOSAIC (Multicentre Obstructive Sleep Apnoea Interventional Cardiovascular) trial randomisd 303 patients with minimally symptomatic OSA to receive either CPAP or standard care for 6 months. Treatment effects of CPAP on P-wave duration, P-wave dispersion, QT interval, QT dispersion, Tpeak-to-Tend (TpTe) and TpTe/QT ratio were analysed.Participants were primarily men (83%). Mean age was 57.8 (7.2) and mean ODI (Oxygen Desaturation Index) at baseline was 13.1/h (12.3). Full 12-lead ECG data was available in 250 patients. Mean (SD) baseline intervals of P-wave duration, P-wave dispersion, QTc interval, QT dispersion, TpTe and TpTe/QT ratio in ms were 87.4 (8.3), 42.3 (11.9), 397.8 (22.7), 43.1 (16.7), 73.5 (13.7) and 0.19 (0.0), respectively. No treatment effect of CPAP on risk markers for AF and SCD was found.There seems to be no effect of CPAP on ECG measures of arrhythmia risk in patients with minimally symptomatic OSA.ISRCTN34164388; Post-results.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 698.1KB, Terms of use)
-
- Publisher copy:
- 10.1136/bmjopen-2015-010150
Authors
- Publisher:
- BMJ Publishing Group
- Journal:
- BMJ Open More from this journal
- Volume:
- 6
- Issue:
- 3
- Pages:
- e010150
- Publication date:
- 2016-03-16
- Acceptance date:
- 2016-01-29
- DOI:
- EISSN:
-
2044-6055
- ISSN:
-
2044-6055
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:611929
- UUID:
-
uuid:aee290d0-dbfc-4e56-ab50-e2a851e7d6ae
- Local pid:
-
pubs:611929
- Source identifiers:
-
611929
- Deposit date:
-
2016-03-29
Terms of use
- Copyright holder:
- Schlatzer et al
- Copyright date:
- 2016
- Notes:
- This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license.
If you are the owner of this record, you can report an update to it here: Report update to this record